Abiopharma

🔍 Nagel Bradley M. (Executive)

Company: Electromed, Inc. (ELMD)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 562 shares of Common Stock at $23.95 per share (Direct)
  Date: 2025-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 16,538.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,300 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,838.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 9,800 shares of Employee Stock Option (right to buy) at $23.95 per share (Derivative)
  Date: 2025-09-02 | Code: A | Expires: 2035-09-02 | equity_swap_involved: 0 | shares_owned_after: 9,800.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents shares forfeit to satisfy tax withholding obligations in connection with vesting of previously awarded shares of restricted stock.
• F2: Restricted stock scheduled to vest in three substantially equal annual installments on each of the first business days of September 2026, 2027 and 2028.
• F3: Options scheduled to vest and become exercisable in three substantially equal annual installments on each of the first business days of September 2026, 2027 and 2028.